E.E.S. 400 Drug Patent Profile
✉ Email this page to a colleague
When do E.e.s. 400 patents expire, and when can generic versions of E.e.s. 400 launch?
E.e.s. 400 is a drug marketed by Arbor Pharms Llc and is included in two NDAs.
The generic ingredient in E.E.S. 400 is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E.e.s. 400
A generic version of E.E.S. 400 was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
Summary for E.E.S. 400
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Formulation / Manufacturing: | see details |
DailyMed Link: | E.E.S. 400 at DailyMed |
Pharmacology for E.E.S. 400
Drug Class | Macrolide Antimicrobial Macrolide |
Physiological Effect | Decreased Sebaceous Gland Activity |
Anatomical Therapeutic Chemical (ATC) Classes for E.E.S. 400
US Patents and Regulatory Information for E.E.S. 400
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-002 | Aug 12, 1982 | BX | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |